• Who we are
    • About GARDP
    • Strategy
      • 5 BY 25
    • Our Team
    • Partners
    • GARDP Worldwide
  • What we do
    • Antibiotic resistance response
    • Pandemic Preparedness
    • Research & Development
      • Discovery & Exploratory Research
      • Children’s antibiotics
      • Sexually transmitted infections
      • Serious bacterial infections
    • Access to Antibiotics
    • REVIVE: Education & Collaboration
    • SECURE: Expanding Sustainable Access to Antibiotics
  • News & resources
    • Press centre
    • Updates
    • Events
    • Stories
    • Viewpoints
    • Publications
    • 日本語資料
  • Take action
    • Learn about antibiotics
    • Become a partner
    • Donate
    • Work for GARDP
    • Request for Proposals
    • Contact us
  • Donate

Antibiotic Development: Economic, Regulatory and Societal Challenges


20 Nov 2019
Årdal, C., Balasegaram, M., Laxminarayan, R. et al.
Antibiotic development — economic, regulatory and societal challenges. Nat Rev Microbiol (2019) doi:10.1038/s41579-019-0293-3

Click here to read the article


More Scientific Articles

← Towards Understanding Global Patterns of Antimicrobial Use and Resistance in Neonatal Sepsis: Insights from the NeoAMR Network
The Global Antibiotic Research and Development Partnership (GARDP) Not-For-Profit Model of Antibiotic Development →

Programmes

Discovery & exploratory
Children’s antibiotics
Sexually transmitted infections
Serious bacterial infections
Access to Antibiotics

More GARDP sites

REVIVE: Education & Collaboration

Contact us

Contacts
Vacancies
Request for Proposals

Sign up to our newsletter to stay connected

Subscribe
  • Terms of use